Literature DB >> 3118361

Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules.

S Huet1, L Boumsell, B Raynal, L Degos, J Dausset, A Bernard.   

Abstract

The immunological function of major histocompatibility complex molecules, including HLA class I molecules, is to present antigens and/or their processed peptides to various lymphocyte subpopulations. Thus, they play a pivotal role in regulatory interactions between cells of the immune system, which can result in the activation and function of T cells. We looked for a role of major histocompatibility complex molecules during T-cell activation induced by monoclonal antibody (mAb) or combinations of mAb recognizing the two well-characterized T-cell surface molecules CD3 and CD2. To activate T-cell peripheral blood lymphocytes, we used a CD3 mAb or two different pairs of CD2 mAb, CD2 "GT2 + T11(1)" and CD2 "D66 + T11(1)," which, as we have previously shown, deliver different signals of activation to T cells. Anti-HLA class I mAb blocked the activation induced by CD3 mAb or by CD2 GT2 + T11(1), but it did not block activation induced by CD2 D66 + T11(1). We observed this pattern of inhibition according to the stimulus used to activate T cells both when the anti-HLA class I mAbs were added to cultures of whole peripheral blood mononuclear cells and when they were fixed to monocytes only. In the latter case, purified monocytes were first incubated with the anti-HLA mAb (whether whole immunoglobulin or Fab fragment) and then fixed with paraformaldehyde before culture with autologous purified T cells. Anti-HLA class I fixed on monocytes prevented both interleukin 2 (IL-2) receptor expression and IL-2 synthesis on T cells. The inhibitory effects of anti-class I mAb bound to monocytes were not reversed by adding large amounts of recombinant IL-2 or recombinant IL-1, a finding consistent with the observations that accessory cells surface components can fully complement the signals directly delivered to T cells by CD2 or CD3 mAb. We conclude that HLA class I from accessory cells plays an important role in the early phase of T-cell activation when direct contacts between accessory cells and T cells are required.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118361      PMCID: PMC299263          DOI: 10.1073/pnas.84.20.7222

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.

Authors:  T D Geppert; P E Lipsky
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

2.  Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody.

Authors:  F A Lemonnier; P P Le Bouteiller; D Olive; B Malissen; Z Mishal; C Layet; J Dubreuil; D H Caillol; F M Kourilsky; B R Jordan
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

Review 3.  Requirement for the involvement of clonally distributed receptors in the activation of cytotoxic T lymphocytes.

Authors:  E L Larsson; M Gullberg; A Beretta; A Coutinho
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  Role of class I and class II antigens in the allogenic stimulation: class I and class II recognition in allogenic stimulation; blocking of MLR by monoclonal antibodies and F(ab')2 fragments.

Authors:  J Kalil; E E Wollman
Journal:  Cell Immunol       Date:  1983-07-15       Impact factor: 4.868

5.  Activation of T lymphocytes by lectins and carbohydrate-oxidizing reagents viewed as an immunological recognition of cell-surface modifications seen in the context of "self" major histocompatibility complex antigens.

Authors:  A Kimura; B Ersson
Journal:  Eur J Immunol       Date:  1981-06       Impact factor: 5.532

6.  On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice.

Authors:  P Parham
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

7.  Mitogenic actions of Orthoclone OKT3 on human peripheral blood lymphocytes: effects of monocytes and serum components.

Authors:  J Van Wauwe; J Goossens
Journal:  Int J Immunopharmacol       Date:  1981

8.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

Authors:  D L Thiele; M Kurosaka; P E Lipsky
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

9.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. "Modulation" of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes.

Authors:  A Bernard; C Gelin; B Raynal; D Pham; C Gosse; L Boumsell
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  5 in total

1.  Inhibition of human immunodeficiency virus type 1 production in infected peripheral blood mononuclear cells by human leukocyte antigen class I-specific antibodies: evidence for a novel antiviral mechanism.

Authors:  L Briant; M Benkirane; M Girard; M Hirn; C Iosef; C Devaux
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.

Authors:  M D Mossalayi; J C Lecron; A H Dalloul; M Sarfati; J M Bertho; H Hofstetter; G Delespesse; P Debre
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

3.  Specific inhibition of OKT3-driven T-cell mitogenesis by an anti HLA-class I monoclonal antibody.

Authors:  I Beckman; X Xiaoning; J Bradley
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

4.  Endocytosis of the class I major histocompatibility antigen via a phorbol myristate acetate-inducible pathway is a cell-specific phenomenon and requires the cytoplasmic domain.

Authors:  G G Capps; M Van Kampen; C L Ward; M C Zúñiga
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

5.  Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy.

Authors:  Kazuyoshi Takeda; Noriko Yamaguchi; Hisaya Akiba; Yuko Kojima; Yoshihiro Hayakawa; Jane E Tanner; Thomas J Sayers; Naoko Seki; Ko Okumura; Hideo Yagita; Mark J Smyth
Journal:  J Exp Med       Date:  2004-02-09       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.